This Weekly’s Hot Topics

  • California Oncology PAC takes position at CMA Specialty Coalition and Council on Legislation meetings(California News)
  • The Angeles Clinic and Research Institute Now Recruiting Patients for TAPUR Clinical Trial (MOASC News)
  • The “right to try” failed to pass by two-thirds majority in a House vote(National News)

 

MOASC & ANCO, with their lobbyist, attended the CMA Specialty Coalition and Council on Legislation meetings last week.  For more information click here and go to California News.

Clinical Laboratory Fee Schedule and Laboratory Services Subject to Reasonable Charge Payment – Quarterly Update – Revised CR10445
CR 10445 which informs the MACs about the changes in the April 2018 quarterly update to the Clinical Laboratory Fee Schedule (CLFS). For more information click here and go to Noridian News.

It has come to MOASC’s attention that some member patients may be in receipt of letters from United Healthcare or other health insurers about a benefit design change, called a “co-pay accumulator” which changes the way patients’ co-pay cards are used towards deductibles/co-pays. Accumulator programs target specialty drugs for which a manufacturer provides copayment assistance. For more information click here and go to MOASC News.

A study conducted by University of Southern California reveals patients overpay for prescriptions 23% of time.  Kaiser Health News highlighted the study explaining the common practice of charging a copay that is higher than the full cost of the drug which is called a “clawback”. For more information click here and go to National News.

 

To view the California Oncology Weekly Newsletter, click on the date below.

March 20, 2018